Beone Medicines Ltd Adr (ONC)

Mar 07, 2025

Beigene CEO John Oyler sells shares worth $14.6 million - Investing.com

Mar 07, 2025

Mar 07, 2025

Beigene’s president Wu Xiaobin sells $13.6 million in shares - Investing.com

Mar 07, 2025

Mar 06, 2025

Beigene chair Wang Xiaodong sells shares worth over $2 million - Investing.com India

Mar 06, 2025

Mar 04, 2025

Beigene president sells economic interest in RMB shares for $1.16 million - Investing.com India

Mar 04, 2025

Mar 04, 2025

China-Based Biotech BeiGene Scores FDA Approval For Tevimbra/Chemo Combo For Untreated Patients With Esophageal Cancer - Benzinga

Mar 04, 2025

Mar 04, 2025

BOCOMI: BEIGENE (06160.HK) Guides to Positive 2025 Operating Profit; Rating Kept at Buy - AASTOCKS.com

Mar 04, 2025

Mar 03, 2025

JPMorgan maintains BeiGene stock Overweight rating, $311 target - Investing.com India

Mar 03, 2025

Mar 03, 2025

Beigene SVP sells $331,375 in American depositary shares By Investing.com - Investing.com South Africa

Mar 03, 2025

Mar 03, 2025

Beigene SVP sells $331,375 in American depositary shares - Investing.com India

Mar 03, 2025

Mar 03, 2025

JPMorgan maintains BeiGene stock Overweight rating, $311 target By Investing.com - Investing.com South Africa

Mar 03, 2025

Mar 03, 2025

BofA lifts BeiGene stock rating, raises target to $320 - Investing.com India

Mar 03, 2025

Mar 03, 2025

BofA lifts BeiGene stock rating, raises target to $320 By Investing.com - Investing.com South Africa

Mar 03, 2025

Feb 28, 2025

Beigene directors Julian and Felix Baker sell $190m in shares - Investing.com India

Feb 28, 2025

Feb 28, 2025

BeiGene gets FDA Orphan Drug Designation for sonrotocla - Investing.com

Feb 28, 2025

Feb 28, 2025

Guggenheim lifts BeiGene stock target to $348, maintains Buy rating - Investing.com India

Feb 28, 2025

Feb 28, 2025

Citizens JMP lifts BeiGene stock target to $348 on strong sales By Investing.com - Investing.com South Africa

Feb 28, 2025

Feb 28, 2025

Citizens JMP lifts BeiGene stock target to $348 on strong sales - Investing.com India

Feb 28, 2025

Feb 27, 2025

AASTOCKS Financial NewsBeiGene, Ltd. (ONC) - AASTOCKS.com

Feb 27, 2025

Feb 27, 2025

UBS Lifts BEIGENE (06160.HK) TP to $330, Rating Buy - AASTOCKS.com

Feb 27, 2025

Feb 27, 2025

BeiGene stock price target raised to $334 at TD Cowen By Investing.com - Investing.com South Africa

Feb 27, 2025

Feb 27, 2025

BeiGene stock price target raised to $334 at TD Cowen - Investing.com

Feb 27, 2025

Feb 27, 2025

BeiGene stock target raised to $308 on strong FY results - Investing.com India

Feb 27, 2025

Feb 27, 2025

BeiGene stock target raised to $308 on strong FY results By Investing.com - Investing.com South Africa

Feb 27, 2025

Feb 27, 2025

BeiGene beats Q4 expectations, sees strong 2025 revenue growth - Investing.com

Feb 27, 2025

Feb 27, 2025

BeiGene beats Q4 expectations, sees strong 2025 revenue growth By Investing.com - Investing.com South Africa

Feb 27, 2025

Feb 25, 2025

Beigene SVP sells shares worth $310,169 By Investing.com - Investing.com South Africa

Feb 25, 2025

Feb 25, 2025

Beigene SVP sells shares worth $310,169 - Investing.com India

Feb 25, 2025

Feb 25, 2025

Beigene's global head of R&D sells $1.29m in shares - Investing.com

Feb 25, 2025

Feb 24, 2025

Beigene, Ltd. (NASDAQ:ONC) COO Xiaobin Wu Sells 21,267 Shares - MarketBeat

Feb 24, 2025

Feb 21, 2025

BeiGene stock soars to 52-week high of $258.66 amid robust growth - Investing.com India

Feb 21, 2025

Feb 21, 2025

BeiGene stock soars to 52-week high of $258.66 amid robust growth By Investing.com - Investing.com South Africa

Feb 21, 2025

Feb 20, 2025

BeiGene’s president sells $12.5 million in company shares - Investing.com India

Feb 20, 2025

Feb 20, 2025

BeiGene's president sells $12.5 million in company shares - Investing.com

Feb 20, 2025

Feb 08, 2025

Beigene's Wang Xiaodong sells $9.4 million in shares - Investing.com India

Feb 08, 2025

Feb 06, 2025

Beigene's Wang Xiaodong sells $9.4 million in shares By Investing.com - Investing.com South Africa

Feb 06, 2025

Feb 03, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Feb 03, 2025

Jan 15, 2025

CCBI Adds BEIGENE's TP to $179 for Better Fundamentals This Yr - AASTOCKS.com

Jan 15, 2025

Jan 13, 2025

BEIGENE (06160.HK) Climbs 6% in Early Session, Expects to Achieve Positive Operating Income This Yr - AASTOCKS.com

Jan 13, 2025

Jan 08, 2025

Beigene director Wang Xiaodong sells $7.37 million in shares - Investing.com

Jan 08, 2025

Jan 05, 2025

HSBC Global Research Prefers BeiGene/ SINO BIOPHARM/ HYGEIA HEALTH Given Higher Visibility in CN Pharma & Medical Device Subsectors - AASTOCKS.com

Jan 05, 2025

Dec 31, 2024

(NASDAQ:BGNE) Stock Quotes, Forecast and News Summary - Benzinga

Dec 31, 2024

Dec 27, 2024

FDA approves BeiGene's TEVIMBRA for advanced gastric cancer treatment - Investing.com

Dec 27, 2024

Dec 24, 2024

With 45% institutional ownership, BeiGene, Ltd. (NASDAQ:BGNE) is a favorite amongst the big guns - Yahoo Finance

Dec 24, 2024

Dec 23, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Dec 23, 2024

Dec 17, 2024

BeiGene shares reiterate Buy rating on robust oncology pipeline - Investing.com

Dec 17, 2024

Dec 10, 2024

Beigene directors sell shares worth $194.2 million - Investing.com

Dec 10, 2024

Dec 04, 2024

Beigene sees $274 million stock sale by Hillhouse Investment By Investing.com - Investing.com

Dec 04, 2024

Nov 30, 2024

10 High Growth Healthcare Stocks to Invest in Now - Insider Monkey

Nov 30, 2024

Nov 29, 2024

Beigene's Wang Xiaodong sells shares worth $9.19 million - Investing.com

Nov 29, 2024

Nov 19, 2024

BeiGene settles patent litigation, extends BRUKINSA exclusivity - Investing.com

Nov 19, 2024